Table 2.
Bodyweight changes of the experimental groups during the subacute period of 28 days.
| Treatment | Bodyweight Development | (g) | |||
|---|---|---|---|---|---|
| 1st Day | 7th Day | 14th Day | 21st Day | 28th Day | |
| Normal Control | 23.4 ± 1.8 | 24.7 ± 1.5 * | 25.2 ± 1.4 *** | 26.9 ± 1.3 *** | 27.2 ± 1.5 *** |
| Diabetic Control | 23.8 ± 1.6 | 21.7 ± 2.2 # | 20.1 ± 2.7 ### | 19.2 ± 2.5 ### | 17.7 ± 2.4 ### |
| D. Glib 2 mg/kg | 24.3 ± 1.6 | 23.1 ± 1.5 | 24.2 ± 1.7 ** | 25.8 ± 1.8 *** | 25.9 ± 1.7 *** |
| D. PCS 25 mg/kg | 22.5 ± 1.9 | 22.1 ± 1.6 | 23.6 ± 1.9 ** | 24.3 ± 1.9 ** | 26.2 ± 2.0 *** |
| D. PCS 50 mg/kg | 21.9 ± 2.0 | 21.2 ± 1.9 | 22.34 ± 2.4 * | 23.2 ± 2.6 ** | 24.8 ± 2.4 *** |
Values are expressed as mean ± SD (n = 5 mice). # p < 0.05, ### p < 0.001 compared to normal control; * p < 0.05, ** p < 0.01, *** p < 0.001 compared to diabetic control.